nandrolone has been researched along with rifampin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Claude, JR; Jacqueson, A; Piriou, A; Thévenin, M; Warnet, JM | 1 |
| Kulagin, IB | 1 |
| Blode, H; Kunz, M; Mellinger, U; Parke, S; Rohde, B; Zeun, S; Zimmermann, T | 1 |
1 trial(s) available for nandrolone and rifampin
| Article | Year |
|---|---|
Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
Topics: Aged; Anti-Infective Agents; Biotransformation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Enzyme Induction; Erythromycin; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Ketoconazole; Middle Aged; Nandrolone; Postmenopause; Rifampin | 2012 |
4 other study(ies) available for nandrolone and rifampin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Study of the protective effect of an anabolic steroid, 19-nortestosterone phenylpropionate (19-NTPP) on the fatty liver induced by high doses of rifampicin in the rat.
Topics: Anabolic Agents; Animals; Castration; Cholesterol; Fatty Liver; Female; Lipids; Male; Nandrolone; Rats; Rifampin; Triglycerides | 1980 |
[A case of acute renal failure after rifampicin use].
Topics: Acute Kidney Injury; Anabolic Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Flavonoids; Furosemide; Humans; Kaempferols; Middle Aged; Nandrolone; Nandrolone Decanoate; Povidone; Rifampin | 1994 |